Eledon Pharmaceuticals, Inc.
NASDAQEledon Pharmaceuticals approaches its May 19 Q1 earnings report with a notable shift in positioning: short sellers have been covering, the stock is up 26% in a month, and the borrow market remains undemanding — a setup that looks more constructive than punishing, even as the ORTEX short score holds elevated at 71. The most meaningful move in the lending market is the retreat in…
Snapshot as of 28 Jun 2026
Eledon Pharmaceuticals approaches its May 19 Q1 earnings report with a notable shift in positioning: short sellers have been covering, the stock is up 26% in a month, and the borrow market remains undemanding — a setup…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ELDN — free to start on ORTEX.
Sign up for free →Open ELDN on ORTEX